-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Reiterates Overweight on Disc Medicine, Maintains $170 Price Target

Benzinga·11/19/2026 11:47:01
Diffusion vocale
Cantor Fitzgerald analyst Kristen Kluska reiterates Disc Medicine (NASDAQ:IRON) with a Overweight and maintains $170 price target.